TuHURA Biosciences (HURA) Net Cash Flow (2010 - 2026)

TuHURA Biosciences' Net Cash Flow history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 141.6% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $78296.0 (down 99.57% YoY), while the FY2025 annual figure was -$9.0 million, down 200.5% from the prior year.
• Net Cash Flow for Q1 2026 stood at $2.7 million, up from $949405.0 in the prior quarter.
• The five-year high for Net Cash Flow was $15.9 million in Q3 2024, with the low at -$8.3 million in Q2 2023.
• The 5-year median for Net Cash Flow is -$1.8 million (2023), against an average of -$423437.2.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow tumbled 262.85% in 2022, then surged 1307.81% in 2024.
• TuHURA Biosciences' Net Cash Flow stood at -$5.4 million in 2022, then soared by 50.56% to -$2.6 million in 2023, then soared by 701.68% to $15.9 million in 2024, then plunged by 94.04% to $949405.0 in 2025, then jumped by 182.09% to $2.7 million in 2026.
• Business Quant data shows HURA's Net Cash Flow at $2.7 million in Q1 2026, $949405.0 in Q4 2025, and -$5.8 million in Q3 2025.